Pfizer hit with $50K fine for Lipitor ads

The makers of Lipitor have been fined $50,000 for advertising direct to the public that the statin was still available despite generic versions of atorvastatin coming on the market.

Pfizer launched the nationwide “Community Service Notification” campaign in early May, saying it was in response to an influx of calls from concerned patients who reported they had been told the branded product was “no longer available” or that it had been “replaced”.

The notification, which ran in consumer newspapers for a week, stated: